Fig. 1From: Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMRClinical findings. a Histological finding of the placenta. b Facial photos at 4 years of age. c Growth chart of this patient. She receives growth hormone (GH) therapy (0.23 mg/kg/week) for short stature born small-for-date from 3 years of ageBack to article page